Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Powell

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
Leukemia|March 9, 2007
Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3))I Molnár, N Stark, J Lovato, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Blood|August 26, 1998
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111R A Larson, R K Dodge, C A Linker, et al.
Blood|July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineR M Stone, D T Berg, S L George, et al.
Leukemia|March 25, 2017
No evidence for microsatellite instability in acute myeloid leukemiaC J Walker, A-K Eisfeld, L K Genutis, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical OncologyC A Schiffer, K C Anderson, C L Bennett, et al.
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.
Leukemia|March 22, 2017
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemiaA-K Eisfeld, K Mrózek, J Kohlschmidt, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
Leukemia|March 9, 2007
Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3))I Molnár, N Stark, J Lovato, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Blood|August 26, 1998
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111R A Larson, R K Dodge, C A Linker, et al.
Blood|July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineR M Stone, D T Berg, S L George, et al.
Leukemia|March 25, 2017
No evidence for microsatellite instability in acute myeloid leukemiaC J Walker, A-K Eisfeld, L K Genutis, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical OncologyC A Schiffer, K C Anderson, C L Bennett, et al.
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.
Leukemia|March 22, 2017
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemiaA-K Eisfeld, K Mrózek, J Kohlschmidt, et al.
Pageof 10